Ignite Creation Date:
2025-12-24 @ 12:20 PM
Ignite Modification Date:
2026-02-08 @ 2:45 PM
Study NCT ID:
NCT04999761
Status:
RECRUITING
Last Update Posted:
2024-09-25
First Post:
2021-07-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
AB122 Platform Study
Sponsor:
Taiho Pharmaceutical Co., Ltd.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Advanced or Metastatic Solid Tumor | View |
| None | Pancreatic Ductal Adenocarcinoma | View |
| None | Colorectal Cancer | View |
| None | Non-small Cell Lung Cancer | View |
| None | Gastric Cancer | View |
| None | Alveolar Soft Part Sarcoma | View |
| None | Esophageal Cancer | View |
| None | Head and Neck Cancer | View |
| None | Biliary Tract Cancer | View |
Keywords: